Lv4
470 积分 2024-07-25 加入
Stage-specificity of STING activation in intrahepatic cholangiocarcinoma determines the efficacy of its agonism
1个月前
已完结
Macrophage-rich niches regulate T cell dynamics at the liver invasive margin during gallbladder cancer progression
1个月前
已完结
HSPA6 Confers Lenvatinib Resistance in Hepatocellular Carcinoma by Promoting Phase Separation-Mediated TXNRD1 Stabilization to Suppress Ferroptosis
1个月前
已完结
Galectin-4 drives anti-PD-L1/BVZ resistance by regulating metabolic adaptation and tumour-associated neutrophils in hepatocellular carcinoma
1个月前
已完结
CA19-9 kinetics during systemic chemotherapy in patients with advanced or recurrent biliary tract cancer
3个月前
已完结
Conversion therapy of tislelizumab plus lenvatinib and GEMOX in unresectable locally advanced biliary tract cancer (ZSAB-TransGOLP): a multicentre, prospective, phase 2 study
4个月前
已完结
Update on immunotherapy in the management of gallbladder cancer
4个月前
已完结
Case Report: Durable Complete Response After Combined Immunotherapy Following Resection of Primary Tumor in a Gallbladder Cancer Patient With Distant Metastatic Lymph Nodes of Favorable Immune-Microenvironment
4个月前
已关闭
Dynamic urinary proteomics integrates single-cell and spatial transcriptomics to reveal tumour microenvironment and predict immunotherapy response in biliary tract cancer
4个月前
已完结
Multi-omic analysis of gallbladder cancer identifies distinct tumor microenvironments associated with disease progression
4个月前
已完结
皖公网安备34019202002308
